A team of leading Japanese medical researchers has issued a red alert after uncovering disturbing links between Covid mRNA shots and surging reports of miscarriages.
The warning was issued in a report from Japanese scientists from the Tokyo-based National Center for Child Health and Development (NCCHD) and the Nippon Sport Science University.
Led by Professor Michi Hisano of the NCCHD’s Center of Maternal-Fetal, Neonatal, and Reproductive Medicine, the team is raising the alarm over troubling findings from a study conducted on 184 hospital staff members who participated in separate prior studies.
The studies were conducted during Japan’s FY 2020 (April 1, 2020 to March 31, 2021) through FY 2022 (April 1, 2022 to March 31, 2023).
The longitudinal studies were conducted with team members associated with Japan’s NCCHD during the COVID-19 pandemic.
The researchers uncovered evidence that “mRNA vaccines pose a theoretical risk of cross-reactivity between the SARS-CoV-2 spike protein and phospholipids in host tissues.”
For the new study, the scientists analyzed the data for FY 2020 through FY 2022.
In the present study, the Japan Health Research Promotion Bureau Research Fund-sponsored team compared serum anti-phospholipid antibody titers prior to, and after COVID-19 mRNA vaccination among 184 hospital staff members.
The study found no significant differences involving antibody titers targeting cardiolipin and β2-glycoprotein I.
However, the scientists warn that “post-vaccination antibody titers targeting phosphatidylethanolamine were found to be significantly increased compared to pre-vaccination levels (p = 0.008).”
Anti-phosphatidylethanolamine antibodies (aPE) are the most common anti-phospholipid antibodies detected in patients with recurrent miscarriages at < 10 weeks of gestation.
aPE are also linked to other associated events, such as vascular thrombosis, myocardial infarctions, and pulmonary thromboembolism.
In addition, numerous troubling reports involve cardiovascular complications in association with Covid mRNA injections, such as thrombosis and heart failure through cardiovascular inflammation.
The presence of serologically persistent anti-phospholipid antibodies is a characteristic of antiphospholipid syndrome (APS).
APS causes clinical manifestations including thrombosis or pregnancy morbidity.
The Japanese researchers conducted the latest study to assess COVID-19 infection rates as well as mental and physical health among healthcare providers.
During the primary study, anti-SARS-CoV-2 spike and nucleocapsid IgG antibody titers were measured in March 2021 for FY2020, July 2021 for FY 2021, and July 2022 for FY2022.
The study involved various surveys involving mental and physical health age, sex, job category, height, weight, history of prior SARS-CoV-2 infection (as diagnosed via PCR), total number of SARS-CoV-2 mRNA vaccination doses received, time of most recent vaccination, and whether they were administered concurrently.
During the FY2021 and FY2022 studies, the investigation was run concurrently with routine annual medical check-ups.
The investigators selected 221 patients of the total participants who had provided consent to use residual serum from the visits in March 2021 and July 2022 for research and had received at least three doses of a Covid mRNA shor as of July 2022.
Applying further exclusion criteria, the study was left with 184 participants, who had their antibody titers to phospholipids measured.
The authors note that they were able to determine changes in anti-PL antibody titers before and post-vaccination, as well as overall immunogenicity levels of the vaccine.
The following table is a comparison of serum antibody titers to phospholipids and SARS-CoV-2 before and after vaccination.
Antibody titers are expressed as mean (standard deviation).
Each sample was considered to be seropositive if the antibody titer was above the positive threshold.
aPE antibodies are a poorly understood autoimmune condition.
However, studies have shown that they are positively correlated with APS’s main clinical manifestations.
In one study, 6.87% of patients with a history of RPL were positive for aPE IgG and 13.6% were positive for aPE IgM, with the cumulative positive aPE group having a miscarriage rate of 32.6%.
In some patients with APS symptoms, aPE antibodies may be the only antibodies present, suggesting that aPE may be an independent etiological entity.
An anti-phosphatidylethanolamine panel is a test that measures antibodies to phosphatidylethanolamine and can be used to diagnose APS.
APS doesn’t always cause noticeable problems, but some people may experience general symptoms similar to multiple sclerosis, such as tiredness, numbness, or tingling.
Doctors note that APS can often go undiagnosed in sufferers.
Following the results of their study, the researchers in Japan have issued a call to action over the disturbing links between Covid mRNA injections and miscarriages.
While this study was limited, the findings expose major concerns with the mRNA COVID-19 shots.
They are now demanding further investigation into the links.
“The long-term safety and efficacy of mRNA-based SARS-CoV-2 vaccines should continue to be scrutinized,” the scientists conclude.
As THAIMBC News has previously reported, scientists have been raising the alarm for some time over the surge in miscarriages and stillbirths since the Covid shots were rolled out in early 2021.
Leading experts are warning that miscarriage rates have soared so dramatically in Covid mRNA-vaccinated women that “millions” of babies have now been lost who should have been born.
